Disposition of [¹⁴C]-LY3337641 Following Oral Administration in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Poseltinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 09 Dec 2016 Status changed from active, no longer recruiting to completed.
- 17 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2016 Status changed from not yet recruiting to recruiting.